ENSG
The Ensign Group Inc
NASDAQ: ENSG · HEALTHCARE · MEDICAL CARE FACILITIES
$169.41
+3.66% today
Updated 2026-06-05
Market cap
$8.73B
P/E ratio
24.33
P/S ratio
1.66x
EPS (TTM)
$6.14
Dividend yield
0.17%
52W range
$135 – $218
Volume
0.5M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A6.5
Quality
B6.0
Profitability
B4.7
Valuation
C4/9
Piotroski F-Score
Moderate
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$220.40
+30.10%
12-Month target
$175.22
+3.43%
Intrinsic (DCF)
$145.42
Margin of safety
-45.73%
1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $64.68M — positive
+ Revenue growth 18.40% QoQ
Risks
- 45.73% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.03B | $3.73B | $4.26B | $5.06B | $5.27B |
| Net income | $224.68M | $209.40M | $297.97M | $343.97M | $99.67M |
| EPS | — | — | — | — | $6.14 |
| Free cash flow | $184.97M | $270.49M | $188.95M | $370.71M | $64.68M |
| Profit margin | 7.43% | 5.61% | 6.99% | 6.80% | 6.89% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-02 | SMITH, BARRY M | Sale | 700 | $164.28 |
| 2026-05-27 | WITTEKIND, BEVERLY B. | Sale | 102 | $171.97 |
| 2026-05-27 | SNAPPER, SUZANNE D. | Sale | 458 | $171.97 |
Peer comparison
Smart narrative
The Ensign Group Inc trades at $169.41. representing a P/E of 24.33x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.15, it sits in the grey zone. TTM revenue stands at $5.27B. with profit margins at 6.89%. Our DCF model estimates intrinsic value at $145.42.
Frequently asked questions
What is The Ensign Group Inc's stock price?
The Ensign Group Inc (ENSG) trades at $169.41, on a P/E of 24.3x and a P/S of 1.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is The Ensign Group Inc overvalued?
The Ensign Group Inc carries a Smart Value Score of 63/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $145.42 against the $169.41 price, so on cash flow terms the market is paying a premium for The Ensign Group Inc's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of The Ensign Group Inc (ENSG)?
The 12-month analyst consensus target is $220.40, about 30.1% above the current $169.41. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of The Ensign Group Inc (ENSG)?
Our DCF model estimates intrinsic value at $145.42, a -45.7% margin of safety versus today's $169.41. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is The Ensign Group Inc's revenue?
The Ensign Group Inc's trailing twelve-month revenue is $5.27B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
The Ensign Group Inc's Altman Z-Score is 2.15, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.66x
ROE15.36%
Beta0.68
50D MA$179.86
200D MA$183.48
Shares out0.06B
Float0.06B
Short ratio—
Avg volume0.5M
Performance
1 week-5.47%
1 month-5.73%
3 months+7.81%
YTD+8.59%
1 year—
3 years—
5 years—